Without changes, including initiatives that help everyone at risk, past progress in slowing IHD’s damage may be further decimated.

The combination of consistent strength training, aerobic activity, and limited sedentary time yielded the greatest benefits.

The results support the potential to change the trajectory of kidney function decline and extend life expectancy.

The data reflect a high degree of technical success, clinical efficacy, and safety of the new technique, says Gennaro Giustino.

South London data show stroke became more common in Black African and Caribbean people but stayed steady in white peers.

Attendees in a SCAI session on cath lab safety and emotional well-being emphasized planning and exercise to stay healthy.

The data show a correlation between wound healing and better participation in social activities, better sleeping habits, and more.

Early right-heart stabilization seems to be translating to better QoL and faster return of function, says Robert Lookstein.

The addition of stenting to usual care reduced symptoms and improved quality of life for patients with the condition after DVT.

Low-income patients receiving a debit card spent most of the money on things upstream of medical care like food and utilities.

The consistent underrepresentation of African populations in clinical studies is a ‘crisis of scientific validity,’ Bamba Gaye says.

Helping patients get groceries and make meals while staying on a DASH-approved diet not only helped, but people liked it, too.

While the noninvasive methods used different technologies to calculate flow, both were noninferior to the gold standard.

Black women had higher rates of premature menopause, but in all women it increased risks of fatal and nonfatal MI by 40%.

Early data from the first phase III trial of Lilly’s triple agonist show reductions in weight and HbA1c for patients with type 2 diabetes.

Data are early, retrospective, and unlikely to influence guidelines, but interest among operators is growing, says Sameh Sayfo.

While the strategies didn’t lower NT-proBNP after PCI in acute MI patients, they may suggest a way forward for intervening early.

Amid late-breaking coronary, structural, and endovascular trials will be a keynote from President Biden, and more.

It may seem overwhelming, but committee chair Karen Joynt Maddox says small changes may help turn things around.

A study shows harm in short-term exposures and proposes a particulate threshold that could influence air quality alerts.

What to make of the results remains uncertain, but experts agree that greater vigilance in low-risk patients is warranted.

Women are less likely than men to receive thrombectomy. New data show the treatment can improve function and quality of life.

Moving to an automatic referral for moderate or severe AS may be an option in some situations, with opt-out caveats.

The inaugural event, lasting 2 days, features deep dives into technical skills, as well as new data and discussion among peers.

Citing lack of robust trial data, the committee offers algorithms and advice on care considerations in premenopausal individuals.

Those with preserved EF seemed to get more protection against HF events/CV death than those with reduced or unknown EF.

The mechanism remains unclear, but GLP-1 users had less MACE, CV death, and all-cause death driven by fewer amputations.

This “long overdue” update expands the pools of patients eligible for thrombolysis and thrombectomy, and tackles pediatric stroke.

Cases exceeding the 90th percentile for dose, though infrequent, resulted in greater cumulative exposures for all cath lab staff.

The results make the case that it isn’t prudent to lump various Asian ethnicities together when trying to gauge care quality.

Suzanne Baron talks with host Yael L. Maxwell about her interest in continuity of care, what it was like to present two late-breaking clinical trials in a single session, and the challenges she’s face...

While frustrating for physicians, the emerging evidence should spur “hypervigilance” around risks that are socially determined.

Some experts questioned advice around protein, dairy, and more but said there are some positive aspects here, too.

Only 12% report having access to a dedicated tobacco treatment team, counselor, or program to counsel patients on quitting.

The disparate cutoffs may help determine whether a patient should go to the cath lab. Prospective validation comes next.

Gene-editing therapy, ACS guidelines, and the death of Dimitrios Karmpaliotis were some of TCTMD’s most-read stories this year.

CLOSURE-AF and CREST-2 were widely read, but stories on GLP-1s, DOACs in AF, and a new PCSK9 inhibitor were popular, too.

Gaxiola López shaped the field of interventional cardiology, with colleagues saying he’ll be remembered as a “visionary.”

Stenting, but not endarterectomy, significantly reduced stroke risk compared with intensive medical therapy alone.

The combination therapy improved LVEF, quality of life, clinical outcomes, and more, but implementation questions remain.

HF outcomes at 3 years were improved, but where stem cells fit in future research is the big unknown, says Jay Traverse.

Changes are afoot to meet higher caseloads amid rising demand, the survey of 6,830 cardiovascular providers suggests.

The pilot study was small, but it suggested music therapy before and during PCI could lower BP and heart rate after PCI.

More focus is needed on female-specific barriers to enrollment and completion of programs that can improve their outcomes.

Elevated lipids increased rates of obstetrical and cardiovascular adverse events over a 5-year follow-up period.